Background: The question of how to manage patients with low-risk papillary thyroid
microcarcinoma (PTMC; T1aN0M0) has recently become an important clinical issue. Two …

Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over
62 000 new cases occurred in men and women in 2015. The incidence continues to rise …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …

The incidence of differentiated thyroid cancer is increasing greatly in high-income countries.
Roughly 50% of this increase is attributable to the identification of intrathyroidal papillary …

Simple Summary The aim of this review is to provide a general overview about the
molecular markers (mutations and alterations) of thyroid cancers, present several molecular …

We are witnessing a rapid worldwide increase in the incidence of papillary thyroid
carcinoma (PTC) in the last thirty years. Extensive implementation of cancer screening and …

Introduction The status of central lymph node metastasis (CLNM) is crucial to determining
the surgical strategies for papillary thyroid micro carcinoma (PTMC). The objective of the …

BRAFV600E mutation is highly prevalent in patients with papillary thyroid carcinoma (PTC),
and TERT promoter (TERTp) mutation is strongly associated with cancer‐related mortality …

Introduction Conservative active surveillance has been proposed for low-risk papillary
thyroid microcarcinoma (PTMC), defined as≤ 1.0 cm and lacking clinical aggressive …

Background In clinical practice, thyroid tumor size plays a critical role in the staging of
thyroid malignancies and in the selection of nodules that should undergo ultrasound-guided …